|
⚲
|
| Keyboard |
| McGlynn Margaret G
✚
|
|
|---|---|
| CIK # | 0001215126 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001215126] | |
| 4 | [0001215126] | |
| 5 | [0001215126] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McGlynn Margaret G | |
| Novavax Inc | |
| Amicus Therapeutics Inc | |
| Vertex Pharmaceuticals Inc / Ma | |
| Air Products & Chemicals Inc /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 28,326 | $6.42 | 181,853 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2025-06-20 | Grant | 18,884 | $0.00 | |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2025-06-12 | Option exercise | 10,420 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2025-06-12 | Option exercise | 10,420 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Stock Options (right to buy) · derivative
|
2025-06-05 | Grant | 74,872 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2025-06-05 | Grant | 20,414 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2024-12-31 | Grant | 1,178 | $8.61 | 10,143 |
|
Novavax Inc NVAX
Common Stock
|
2024-09-30 | Grant | 778 | $12.77 | 9,935 |
|
Novavax Inc NVAX
Common Stock
|
2024-06-30 | Grant | 713 | $13.93 | 9,932 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2024-06-12 | Option exercise | 6,670 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2024-06-12 | Option exercise | 6,670 | $0.00 | |
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2024-06-12 | Grant | 15,630 | $15.86 | 247,892 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2024-06-12 | Grant | 10,420 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2024-06-06 | Grant | 11,847 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Stock Options (right to buy) · derivative
|
2024-06-06 | Grant | 42,467 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2024-03-31 | Grant | 2,029 | $4.90 | 9,942 |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2024-03-05 | Option exercise | 7,500 | $2.80 | 21,000 |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2024-03-05 | Sell | 7,500 | $13.40 | 100,500 |
|
Amicus Therapeutics Inc FOLD
Stock Options (right to buy) · derivative
|
2024-03-05 | Option exercise | 7,500 | $0.00 | |
|
Amicus Therapeutics Inc FOLD
Common Stock
|
2024-03-04 | Sell | 7,500 | $13.29 | 99,675 |
| showing 20 of 200 most recent transactions | |||||